Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
RVMD holding history
Revolution Medicines, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVMD overviewAll 13F holders of RVMDFull Q2 2026 holdings
- Shares (Q2 2026)
- 8,467
- Value
- $1.59M
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,467 | $1.59M | <0.1% | +3,722+78.4% | Added | Holders |
| Q1 2026 | 4,745 | $461.5K | <0.1% | −7,714−61.9% | Reduced | Holders |
| Q4 2025 | 12,459 | $992.4K | <0.1% | +12,459 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −1,170−100.0% | Sold out | Holders |
| Q4 2024 | 1,170 | $51.2K | <0.1% | −83,624−98.6% | Reduced | Holders |
| Q3 2024 | 84,794 | $3.85M | <0.1% | +83,325+5,672.2% | Added | Holders |
| Q2 2024 | 1,469 | $57.0K | <0.1% | −4,606−75.8% | Reduced | Holders |
| Q1 2024 | 6,075 | $195.8K | <0.1% | +6,075 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −13,200−100.0% | Sold out | Holders |
| Q4 2021 | 13,200 | $332.0K | <0.1% | +13,200 | New | Holders |